Pharmacotherapy of depression in oldage

被引:0
|
作者
Hegerl, U [1 ]
Möller, HJ [1 ]
机构
[1] Univ Munich, Psychiat Klin, Abt Klin Neurophysiol, D-80336 Munich, Germany
来源
NERVENARZT | 2000年 / 71卷 / 01期
关键词
depression; antidepressants; older age; SSRI; comorbidity;
D O I
10.1007/s001150050001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Antidepressants are not only effective in younger adults but also in older persons with depression. However there a re pecularities, which have to be taken into account when treating older patients. The enhanced risk of side effects has to be balanced with the more serious consequences of an untreated depression in old age. The efficacy in older patients has been proven not only for tricyclic antidepressants but also for SSRI and other newer antidepressants. The easy handling, the side effect profile and the safety in overdose are advantages of SSRI and newer antidepressants, which become particularly important in old age. The advantages and disadvantages of different classes of antidepressants with regard to comorbidity and comedication are discussed. In older subjects, changes of dosage should be slower and for some, but not for all antidepressants, dosage should be lower.
引用
收藏
页码:1 / 8
页数:10
相关论文
共 50 条
  • [41] When depression is diagnosed, older adults are as likely as younger adults to be prescribed pharmacotherapy and psychotherapy
    Choi, Namkee G.
    DiNitto, Diana M.
    Marti, C. Nathan
    Kunik, Mark E.
    GENERAL HOSPITAL PSYCHIATRY, 2016, 43 : 6 - 11
  • [42] The Impact of Psychotherapy, Pharmacotherapy, and Their Combination on Quality of Life in Depression
    IsHak, Waguih William
    Ha, Khanh
    Kapitanski, Nina
    Bagot, Kara
    Fathy, Hassan
    Swanson, Brian
    Vilhauer, Jennice
    Balayan, Konstantin
    Bolotaulo, Nestor Ian
    Rapaport, Mark Hyman
    HARVARD REVIEW OF PSYCHIATRY, 2011, 19 (06) : 277 - 289
  • [43] Psychotherapy and combined psychotherapy/pharmacotherapy for late life depression
    Areán, PA
    Cook, BL
    BIOLOGICAL PSYCHIATRY, 2002, 52 (03) : 293 - 303
  • [44] Depression, Anxiety, and Pharmacotherapy Around the Time of Pregnancy in Hawaii
    Emily K. Roberson
    Eric L. Hurwitz
    Dongmei Li
    Robert V. Cooney
    Alan R. Katz
    Abby C. Collier
    International Journal of Behavioral Medicine, 2016, 23 : 515 - 526
  • [45] Depression, Anxiety, and Pharmacotherapy Around the Time of Pregnancy in Hawaii
    Roberson, Emily K.
    Hurwitz, Eric L.
    Li, Dongmei
    Cooney, Robert V.
    Katz, Alan R.
    Collier, Abby C.
    INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 2016, 23 (04) : 515 - 526
  • [46] Psychotherapy Versus Pharmacotherapy of Depression: What's the Evidence?
    Leichsenring, Falk
    Steinert, Christiane
    Hoyer, Juergen
    ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE, 2016, 62 (02): : 190 - 195
  • [47] Depression in Parkinson's disease. The role of pharmacotherapy
    Wierzbinski, Piotr
    Sobow, Tomasz
    AKTUALNOSCI NEUROLOGICZNE, 2018, 18 (01): : 14 - 20
  • [48] Prevention of Poststroke Depression: Does Prophylactic Pharmacotherapy Work?
    Salter, Katherine L.
    Foley, Norine C.
    Zhu, Lynn
    Jutai, Jeffrey W.
    Teasell, Robert W.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2013, 22 (08) : 1243 - 1251
  • [49] Influence of Pharmacotherapy on Cognitive Functions in Depression: A Review of the Literature
    Orzechowska, Agata
    Filip, Maria
    Galecki, Piotr
    MEDICAL SCIENCE MONITOR, 2015, 21 : 3643 - 3651
  • [50] Cross-generational comparison of dispensed pharmacotherapy for depression
    Sewitch, Maida J.
    Bexton, Brian
    Rahme, Elham
    Galarneau, Sophie
    Blais, Regis
    INTERNATIONAL JOURNAL OF HEALTH CARE QUALITY ASSURANCE, 2009, 22 (03) : 300 - +